PUBLICACIÓN
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
Munoz Builes M. et al.
2020 BMJ Open
Medicine (miscellaneous) (Q1)
JCR: 2.692
SJR: 1.132
CITAS
13
DOI
10.1136/bmjopen-2019-029642
EID
2-s2.0-85077708109
EISSN
2044-6055
AUTORES DE LA UEX